0
2022
Transdermal Drug Delivery Systems Market

Transdermal Drug Delivery Systems Market

by Type Of Delivery System (Passive, Active), by Application (Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

✷  Report Code: A00385
Pages: 175
Mar 2022 | 15931 Views
Author(s) : Priyanka Rajkumar Khandelwal , Onkar Sumant
Tables: 120
Charts: 56
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

Transdermal Drug Delivery Systems Market Statistics, 2030

The global transdermal drug delivery systems market size was $52,476.50 million in 2020, and is projected to reach $87,322.40 million by 2030, growing at a CAGR of 4.9% from 2021 to 2030. Transdermal drug delivery systems are an alternative to oral intravascular, subcutaneous, and transmucosal routes, wherein the drugs are delivered through the skin for therapeutic use. Transdermal drug delivery systems offer a painless method of systematic drug delivery by application of drug onto an intact and healthy skin.

The transdermal drug delivery systems market has been negatively impacted by COVID-19, due to lockdown in several countries globally.

The rise in global population has significantly increased the demand for geriatric medicines. Transdermal drug delivery systems help deliver drugs in a controlled manner, thereby increasing the effectiveness of geriatric medicines. Furthermore, the number of patients suffering from chronic diseases, such as heart diseases, diabetes, and arthritis has significantly increased in the past few decades. Such chronic diseases are a leading cause of disability and deaths globally. These factors have increased R&D activities that are aimed to enhance the effectiveness of medicines. In addition, awareness amongst patients, regarding the use of various medicines has also increased. These factors have positively influenced the transdermal drug delivery systems market growth.

According to Department of Economic and Social Affairs, United Nations, the total number of people aged 60 years and above was 962 million in 2017, which is more than twice as large as it was in 1980 when there were around 382 million globally. Furthermore, the number of older persons is expected to double again by 2050, nearly reaching 2.1 billion. This s expected to propel the demand for geriatric diseases, thereby positively influencing the transdermal drug delivery systems market. According to Centers for Disease Control and Prevention, an entity of the U.S. Department of Health & Human Services, 6 in every 10 American adults have a chronic disease and 4 in every 10 American adults have two or more chronic diseases. This has significantly increased the spending on healthcare services. According to the U.S. Centers for Medicare & Medicaid Services, the U.S. healthcare spending reached $4.1 trillion or $12,530 per person, witnessing a rise of 9.7%, and accounting for 19.7% of GDP in the U.S. in 2020.

Transdermal Drug Delivery Systems Market
By Type Of Delivery System

Your browser does not support the canvas element.

The active segment is expected to exhibit the fastest growth rate throughout the study period.

Get more information on this report : Request Sample Pages

The novel coronavirus (COVID-19) has rapidly spread across various countries and regions, causing an enormous impact on the lives of people and the overall community. It began as a human health condition and has now become a significant threat to global trade, economy, and finance. The COVID-19 pandemic increased the importance of government healthcare facilities, thereby increasing healthcare spendings across the globe. Furthermore, the number of COVID-19 cases are expected to reduce in the near future as the vaccine for COVID-19 is introduced in the market. This has led to the reopening of transdermal drug delivery system research facilities at full-scale capacities. This is expected to help the market to recover by the start of 2022. After COVID-19 infection cases begin to decline, companies involved in manufacturing of transdermal drug delivery systems must focus on protecting their staff, operations, and supply networks to respond to urgent emergencies and establish new methods of working.

Furthermore, transdermal drug delivery systems offer additional advantages, such as maintaining an adequate concentration of drug in the blood for an extended period of time. It can be discontinued easily by peeling off the patch. In addition, transdermal drug delivery systems can be easily used in infants, elderly people, and patients suffering from dysphagia. Also, advancements in technology have enabled application of transdermal drug delivery systems for a wide range of medications.

Transdermal Drug Delivery Systems Market
By Application

Your browser does not support the canvas element.

The analgesics segment is expected to lead the market throughout the study period.

Get more information on this report : Request Sample Pages

The transdermal drug delivery systems market is segmented on the basis of type of delivery, application, and region. By type of delivery, the market is categorized into passive, active, and others. On the basis of application, it is categorized into analgesics, hormone replacement therapy, hypertension, motion sickness, smoking cessation and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America held the largest transdermal drug delivery systems market share in 2020, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in population and rise in spending of healthcare facilities.

Transdermal Drug Delivery Systems Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America holds the dominat position throughout the study period.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders

  • The report provides an extensive analysis of the current and emerging transdermal drug delivery systems market trends and dynamics. 
  • In-depth transdermal drug delivery systems market analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
  • Extensive analysis of the transdermal drug delivery systems market size is conducted by following key product positioning and monitoring of top competitors within the market framework.
  • A comprehensive analysis of all the regions is provided to determine the prevailing transdermal drug delivery systems market opportunities.
  • The global transdermal drug delivery systems market forecast analysis from 2021 to 2030 is included in the report.
  • The key players within transdermal drug delivery systems market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the transdermal drug delivery systems industry.

Transdermal Drug Delivery Systems Market Report Highlights

Aspects Details
BY TYPE OF DELIVERY SYSTEM
  • Passive
  • Active
BY APPLICATION
  • Analgesics
  • Hormone Replacement Therapies
  • Hypertension
  • Motion Sickness
  • Smoking Cessation
  • Others
BY REGION
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
  • North America  (U.S, Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
Key Market Players Viatris Inc., Bayer AG, Boehringer Ingelheim GmbH, Endo International plc, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Purdue Pharma L.P., Altaris, Hisamitsu Pharmaceutical Co. Inc.
 

Loading Table Of Content...


 
 

The transdermal drug delivery systems market witnessed significant growth in past few years, owing to rapid growth of pharmaceutical industry across the globe and increase in spending on healthcare facilities in developing countries.

Rise in demand for pharmaceutical products fueled by increase in global population and rise in number of lifestyle diseases boosted the demand for transdermal drug delivery systems in the pharmaceutical industry. Furthermore, rise in geriatric populations created a rise in demand for effective drug delivery systems. Also, use of transdermal delivery system helps in controlling the dosage of drug to be given, and proves to be significantly more effective for analgesics. In addition, medication from transdermal drug delivery systems can easily be discontinued by peeling off the patch.

Moreover, supportive government initiatives and rapid growth of the pharmaceutical industry in emerging countries provide lucrative growth opportunities for the transdermal drug delivery systems market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. North America is the largest regional market for transdermal drug delivery system.

A. Business expansion is key growth strategy of transdermal drug delivery system industry players

A. Altaris, Johnson & Johnson, GlaxoSmithKline plc and Hisamitsu Pharmaceutical Co. Inc. are some of the top companies to hold the market share in transdermal drug delivery system.

A. The company profile has been selected on factors such as geographical presence, market dominance (in terms of revenue and volume sales), various strategies and recent developments.

A. In 2020, $52,476.5 million is the estimated industry size of transdermal drug delivery system.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
Transdermal Drug Delivery Systems Market

Start reading instantly.
This Report and over 18,881+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,565
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Data Pack
  • $3,961
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Single User
  • $5,540
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Five Users
  • $6,654
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Enterprise
    License/PDF

  • $10,280
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers